# INTREPId (NCT04025372)

> INTREPId (INTermediate Risk Erection PreservatIon Trial)

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT04025372
- Phase: PHASE2
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: Brigham and Women's Hospital
- Conditions: Prostate Cancer
- Interventions: Bicalutamide; GnRH Agonist; Radiation Therapy; Darolutamide
- Enrollment: 234
- Primary outcome: The percentage of patients with a PSA nadir <= 0.5

## Indexed commentary on INTREPId so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- 3 posts on X

## Order

Focused, $750 at most (a smaller delivered size costs its own price): https://www.erudio.com/contact?report=intrepid-nct04025372